Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Published:2022-07 Issue:10349 Volume:400 Page:369-379
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Deodhar Atul,Van den Bosch Filip,Poddubnyy Denis,Maksymowych Walter P,van der Heijde Désirée,Kim Tae-Hwan,Kishimoto Mitsumasa,Blanco Ricardo,Duan Yuanyuan,Li Yihan,Pangan Aileen L,Wung Peter,Song In-Ho

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Axial spondyloarthritis;Navarro-Compán;Ann Rheum Dis,2021

2. Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts;Boel;Ann Rheum Dis,2019

3. Axial spondyloarthritis;Sieper;Lancet,2017

5. Characteristics and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis: a comparison by systematic literature review and meta-analysis;López-Medina;RMD Open,2019

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease;Cytokine & Growth Factor Reviews;2024-10

2. Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis;Arthritis & Rheumatology;2024-09-08

3. Nociplastic pain in axial spondyloarthritis and psoriatic arthritis: role of JAK kinases in immunopathology and therapeutic impact of JAK inhibitors;Expert Review of Clinical Immunology;2024-09-08

4. Newer Therapies in Rheumatology;Medical Clinics of North America;2024-09

5. Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol;BMJ Open;2024-09